I propose to take Questions Nos. 647 and 775 together.
As part of Budget 2023, I announced €32.2 million in funding for Women’s Health Initiatives in 2023, to include dedicated funding for Cariban. The dedicated funding for Cariban will help women who experience hyperemesis gravidarum, a severe form of morning sickness, during pregnancy.
The HSE asked the Medicines Management Programme to examine the appropriateness and feasibility of a patient specific arrangement for the product.
The HSE Medicines Management Programme assessment for Cariban has now been completed, and their recommendations will be followed in providing access to patients. Cariban will be funded from January 1st 2023.